Most interesting parts:
Quote:
Just one strong dose of hallucinogenic mushrooms can alter a person's personality for more than a year and perhaps permanently, a new study finds.
People given psilocybin, the compound in "magic mushrooms" that causes hallucinations and feelings of transcendence, demonstrated a more "open" personality after their experience, an effect that persisted for at least 14 months. Openness is a psychological term referring to an appreciation for new experiences. People who are more open tend to have broad imaginations and value emotion, art and curiosity.
This personality warp is unusual, said study researcher Katherine MacLean, because personality rarely changes much after the age of 25 or 30. (In fact, one recent study found that by first grade our personalities are set pretty much for life.)
...
The results, published today (Sept. 29) in the Journal of Psychopharmacology, revealed that while other aspects of personality stayed the same, openness increased after a psilocybin experience. The effect was especially persistent for those who reported a "mystical" experience with their dose. These mystical experiences were marked by a sense of profound connectedness, along with feelings of joy, reverence and peace, MacLean said. [Top 10 Mysteries of the Mind]
"It's probably not just psilocybin that causes changes like this, but more these kinds of profound life-changing experiences, whatever flavor they take," she said. "For a lot of people, psilocybin allows them to transcend their ways of thinking about the world."
About 30 of the 51 volunteers had a mystical experience, MacLean said. The openness changes in these participants were larger than those changes typically seen over decades of life experience in adults.
...
In Massachusetts, the nonprofit research institute MAPS, or Multidisciplinary Association for Psychedelic Studies, is investigating the possibility of using the hallucinogen MDMA to treat post-traumatic stress disorder. Both LSD and psilocybin are under investigation for their use in treating anxiety; MacLean's postdoctoral adviser at Johns Hopkins, Ronald Griffiths, is leading a study to find out if psilocybin might ease anxiety and depression in cancer patients. Another of Griffiths' studies focuses on using psilocybin to break nicotine addiction.
People given psilocybin, the compound in "magic mushrooms" that causes hallucinations and feelings of transcendence, demonstrated a more "open" personality after their experience, an effect that persisted for at least 14 months. Openness is a psychological term referring to an appreciation for new experiences. People who are more open tend to have broad imaginations and value emotion, art and curiosity.
This personality warp is unusual, said study researcher Katherine MacLean, because personality rarely changes much after the age of 25 or 30. (In fact, one recent study found that by first grade our personalities are set pretty much for life.)
...
The results, published today (Sept. 29) in the Journal of Psychopharmacology, revealed that while other aspects of personality stayed the same, openness increased after a psilocybin experience. The effect was especially persistent for those who reported a "mystical" experience with their dose. These mystical experiences were marked by a sense of profound connectedness, along with feelings of joy, reverence and peace, MacLean said. [Top 10 Mysteries of the Mind]
"It's probably not just psilocybin that causes changes like this, but more these kinds of profound life-changing experiences, whatever flavor they take," she said. "For a lot of people, psilocybin allows them to transcend their ways of thinking about the world."
About 30 of the 51 volunteers had a mystical experience, MacLean said. The openness changes in these participants were larger than those changes typically seen over decades of life experience in adults.
...
In Massachusetts, the nonprofit research institute MAPS, or Multidisciplinary Association for Psychedelic Studies, is investigating the possibility of using the hallucinogen MDMA to treat post-traumatic stress disorder. Both LSD and psilocybin are under investigation for their use in treating anxiety; MacLean's postdoctoral adviser at Johns Hopkins, Ronald Griffiths, is leading a study to find out if psilocybin might ease anxiety and depression in cancer patients. Another of Griffiths' studies focuses on using psilocybin to break nicotine addiction.
Yay tripping for science!